Skip to main content
MedPathMedPath Home
Clinical Trials/KCT0008616
KCT0008616
Not yet recruiting
未知

Preliminary studies to expand the indications of fecal microbiota transplantation

Inha University Hospital0 sites100 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Inha University Hospital
Enrollment
100
Status
Not yet recruiting
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional Study
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • •\[1] FMT group
  • •1\. Men and women over 18 years of age
  • •2\. Patients who was finally diagnosed as irritable bowel syndrome
  • •\[2] Control group
  • •1\. Men and women over 18 years of age
  • •2\. Patients who was finally diagnosed as irritable bowel syndrome
  • •3\. FMT treatment is rejected but those who agree to participate in this study as a control group

Exclusion Criteria

  • •1\. Patients who need urgent treatment such as acute infectious diseases.
  • •2\. Patients with the disease\-causing severe immunosuppression.
  • •3\. Pregnant women
  • •4\. Patients to be inappropriate for the study when judged by the researchers

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Not Applicable
Effect and safety for clearance of ulcerative colitis in feces through fecal microbiota transplantatio
KCT0008663Inha University Hospital70
Not yet recruiting
Not Applicable
Effect and safety for clearance of vancomycin-resistant enterococci in feces through fecal microbiota transplantatioCodes for special purposes
KCT0007585Inha University Hospital280
Not yet recruiting
Not Applicable
Effect and safety for clearance of carbapenem-resistant enterobacteriaceae in feces through fecal microbiota transplantatio
KCT0007561Inha University Hospital74
Recruiting
Phase 1
Fuzheng huayu tablets against renal fibrosis in primary glomerulonephritis (CKD stage 3): a randomized, double-blind, placebo-controlled, multicenter clinical trialPrimary glomerulonephritis (CKD Stage 3)
ITMCTR2100004925Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Completed
Not Applicable
Pilot study to explore additional indication of therapeutic hypothermia for neonateseonatal encephalopathy
JPRN-UMIN000035536Kurume University School of Medicine30